Biomarx
PrivateLast Round
Pre Seed
Jan 5, 2026
Total Funding Raised
$948,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biomarx is a medtech company that provides a platform for rapid, reliable, and affordable molecular diagnostic solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomarx Comparables
Compare Biomarx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QuantuMDx | 76% | |
| FluxErgy | 74% | |
| genedrive plc | 71% | |
Biomarx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 5, 2026 | ||||
| Seed | Oct 13, 2025 |
Biomarx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Clarendon Fund Managers | Pre Seed |
| University of Strathclyde | Pre Seed |
| Techstart Ventures | Pre Seed |
| SFC Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
$948K round led by SFC Capital and Clarendon Fund Managers.
Biomarx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biomarx's valuation, stock price, and market status.